The Prognostic Value of Pretherapeutic Tetranectin and CA-125 in Patients with Relapse of Ovarian Cancer

By Deng X.   Hogdall E.V.S.   Hogdall C.K.   Norgaard-Pedersen B.   Jorgensen M.   Nielsen H.   Engelholm S.A.A.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 416-419

Elsevier

Access to resources Recommend Favorite

Predictive and Prognostic Values of Cancer-Associated Serum Antigen (CASA) and Cancer Antigen 125 (CA 125) Levels Prior to Second-Look Laparotomy for Ovarian Cancer

By Kierkegaard O.   Mogensen O.   Mogensen B.   Jakobsen A.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 251-254

Academic Press

Access to resources Recommend Favorite

The prognostic role of cancer-specific beliefs among prostate cancer survivors

By Soler-Vilá Hosanna  

Cancer Causes and Control, Vol. 22, Iss. 2, 2011-02 ,pp. : 251-260

Springer Publishing Company

Access to resources Recommend Favorite

Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian Cancer

By But I.   Gorisek B.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 166-172

Academic Press

Access to resources Recommend Favorite

Initial Immunochemical Characterization of MX35 Ovarian Cancer Antigen

By Welshinger M.   Yin B.W.T.   Lloyd K.O.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 188-192

Elsevier

Access to resources Recommend Favorite